14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 20 May 2024

CLVS Predictions History

4 years ago
JS predicted that CLVS for 2019-12-09 is going $10.46 (-2.33%)

4 years ago
JoshuaPhilippon129636 predicted that CLVS for 2019-12-09 is going

Rank:

4 years ago
Mario129651 predicted that CLVS for 2019-12-09 is going

Rank:

4 years ago
Dolphin predicted that CLVS for 2019-12-06 is going

Rank:

4 years ago
Brad Perling predicted that CLVS for 2019-12-02 is going

Rank:

4 years ago
128444 predicted that CLVS for 2019-11-25 is going

Rank:

4 years ago
JS predicted that CLVS for 2019-11-11 is going $5.19 (-11.73%)

5 years ago
NameNotImportant predicted that CLVS for 2019-05-06 is going $19.43 (1.73%)

5 years ago
NameNotImportant predicted that CLVS for 2019-04-30 is going $18.52 (1.37%)

5 years ago
NameNotImportant predicted that CLVS for 2019-04-29 is going $19.30 (1.21%)

Click to get the best stock tips daily for free!

About Clovis Oncology

Clovis Oncology Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, as well as for metastatic castration-resistant prostate cancer. In Europe, the... CLVS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT